CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $648,000 | -10.9% | 32,910 | -0.5% | 0.02% | -11.8% |
| Q2 2021 | $727,000 | -7.0% | 33,060 | +0.5% | 0.02% | -10.5% |
| Q1 2021 | $782,000 | -8.6% | 32,880 | +0.5% | 0.02% | -13.6% |
| Q4 2020 | $856,000 | +119.5% | 32,710 | +45.8% | 0.02% | +100.0% |
| Q3 2020 | $390,000 | +5.4% | 22,436 | +2.0% | 0.01% | 0.0% |
| Q2 2020 | $370,000 | +53.5% | 22,000 | +8.4% | 0.01% | +22.2% |
| Q1 2020 | $241,000 | -2.0% | 20,300 | 0.0% | 0.01% | +28.6% |
| Q4 2019 | $246,000 | -10.5% | 20,300 | +4.5% | 0.01% | -12.5% |
| Q3 2019 | $275,000 | +27.9% | 19,430 | +1.0% | 0.01% | +33.3% |
| Q2 2019 | $215,000 | -8.9% | 19,240 | -4.3% | 0.01% | -14.3% |
| Q1 2019 | $236,000 | -12.6% | 20,110 | -0.5% | 0.01% | -12.5% |
| Q4 2018 | $270,000 | -44.7% | 20,220 | -41.9% | 0.01% | -33.3% |
| Q3 2018 | $488,000 | -9.6% | 34,830 | +1.3% | 0.01% | -14.3% |
| Q2 2018 | $540,000 | +1.7% | 34,380 | +6.4% | 0.01% | 0.0% |
| Q1 2018 | $531,000 | – | 32,310 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,003,723 | $95,164,000 | 6.41% |
| TANAKA CAPITAL MANAGEMENT INC | 65,609 | $780,000 | 3.41% |
| S&T BANK/PA | 588,620 | $6,999,000 | 1.93% |
| Parallel Advisors, LLC | 1,405,895 | $16,716,000 | 1.35% |
| Matarin Capital Management, LLC | 623,915 | $7,418,000 | 1.15% |
| AJ WEALTH STRATEGIES, LLC | 668,020 | $7,943,000 | 1.08% |
| Capital Impact Advisors, LLC | 177,300 | $2,108,000 | 0.88% |
| Alambic Investment Management, L.P. | 29,547 | $351,000 | 0.85% |
| OXFORD FINANCIAL GROUP, LTD. LLC | 332,436 | $3,953,000 | 0.79% |
| Spark Investment Management LLC | 116,400 | $1,383,000 | 0.74% |